That's a lot of volume going through today, page-23

Hi Fattchoi,

How many, many times has this discussion come up in regards to share consolidation over the past number of years?

@Paulfool, I think the Pfizer example of ~5.6 billion shares was a good one. Share Consolidation is not on the “to do list” for IMU.

Having such a large share registry certainly hasn’t hurt us, especially of late. We are sitting on a stack of cash to fund clinical trials ongoing in multiple platforms & cornerstone investors willing to be onboard & a heavily oversubscribed SPP.

I truly just feel that it’s a matter of patience for investors here, not to get spooked by newspaper articles, and rumours & the everyday ups & downs if you are not trading & holding long. The last 2 ROTH targets were hit quite quickly. The latest from Bell Potter is 52c. I think that was before admission to ASX 300.

It’s already ‘dream come true’ stuff for a lot of long term holders, but we are only really beginning to really fire up in the clinic on multiple platforms.

So to think that with such a large share registry & MC, & investing in the here & now, that you won’t make good returns, I believe is a fallacy. As long as we continue to progress in novel cancer immunotherapies.

I hope the AFR Journalist who put out a few things recently that came across in a negatively slanted way pulls his head in sometime soon.

That day we had a big dump of shares, the trolls came out & fast forward to now. What did any of this achieve for SH apart from maybe some unnecessary hypertension & disappointment at SP some people selling their shares around where they bought, we are sitting now in SP? It’s not the first time. It wasn’t even related to FA of IMU’s pipeline.

Definitely don’t believe everything you read, do your own DD & research.

GLTAH